Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary data
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giraud, M.
Right arrow Articles by Garchon, H.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giraud, M.
Right arrow Articles by Garchon, H.-J.
Related Collections
Right arrow Myasthenia
Right arrow Genetic linkage
Neurology 2001;57:1555-1560
© 2001 American Academy of Neurology
Articles

Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies

M. Giraud, MSc, G. Beaurain, PhD, A. M. Yamamoto, PhD, B. Eymard, MD PhD;, C. Tranchant, MD, P. Gajdos, MD and H.-J. Garchon, MD PhD

From INSERM U25 (Drs. Beaurain and Garchon, and M. Giraud), Centre de l’Association Claude Bernard (Dr. Beaurain), and Laboratoire Central d’Immunologie (Dr. Yamamoto), Hôpital Necker, Paris; Service de Neurologie (Dr. Eymard), Institut de Myologie, Hôpital de la Salpêtrière, Paris; Service de Neurologie (Dr. Tranchant), Hôpital Civil, CHRU Strasbourg; and Service de Réanimation (Dr. Gajdos), Hôpital Raymond Poincaré, Garches, France.

Address correspondence and reprint requests to Dr. H.-J. Garchon, INSERM U25, Hôpital Necker, 161 rue de Sèvres, 75743 Paris cedex 15, France; e-mail: garchon{at}necker.fr

Background:— MG is an autoimmune disease of the neuromuscular junction. MG with thymus hyperplasia has been associated with, but not genetically linked to, the HLA-DR3 haplotype.

Objective:— To re-evaluate the association of HLA with MG in 656 patients with generalized disease and to test linkage of HLA to MG with thymus hyperplasia.

Method:— Patients were genotyped for HLA-DRB1. Data analysis included case-control comparisons after subgrouping patients by thymus histopathology. The transmission of parental alleles to MG offspring with thymus hyperplasia was studied in simplex families using the transmission/disequilibrium test (TDT) as a test of linkage.

Results:— MG with thymus hyperplasia was positively associated with DR3 (OR = 4.5, p = 1 x 10-6) and negatively associated with DR7 (OR = 0.28, p = 1 x 10-6), based on both case-control comparisons and TDT. No association was detected with thymomas. Conversely, patients who lacked thymus anomalies but expressed anti-titin antibodies (ATA) had an increase of DR7 (OR = 2.08, p = 4 x 10-3) and a decrease of DR3 (OR = 0.33, p = 9 x 10-3).

Conclusions:— The authors established linkage of HLA to MG and thymus hyperplasia, defining the MYAS1 locus. Moreover, DR3 and DR7, or closely linked genes, have opposing effects on MG phenotypes. Nonthymomatous patients with ATA may be a pathogenetically distinct subset of MG patients.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
International MHC and Autoimmunity Genetics Networ, J. D. Rioux, P. Goyette, T. J. Vyse, L. Hammarstrom, M. M. A. Fernando, T. Green, P. L. De Jager, S. Foisy, J. Wang, et al.
Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases
PNAS, November 3, 2009; 106(44): 18680 - 18685.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
C. Amdahl, E. H. Alseth, N. E. Gilhus, H. L. Nakkestad, and G. O. Skeie
Polygenic Disease Associations in Thymomatous Myasthenia Gravis
Arch Neurol, December 1, 2007; 64(12): 1729 - 1733.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
E. H. Niks, J.B.M. Kuks, B. O. Roep, G. W. Haasnoot, W. Verduijn, B. E.P.B. Ballieux, M. H. De Baets, A. Vincent, and J. J.G.M. Verschuuren
Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5
Neurology, June 13, 2006; 66(11): 1772 - 1774.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Colombara, V. Antonini, A. P. Riviera, F. Mainiero, R. Strippoli, M. Merola, G. Fracasso, O. Poffe, N. Brutti, G. Tridente, et al.
Constitutive Activation of p38 and ERK1/2 MAPKs in Epithelial Cells of Myasthenic Thymus Leads to IL-6 and RANTES Overexpression: Effects on Survival and Migration of Peripheral T and B Cells
J. Immunol., November 15, 2005; 175(10): 7021 - 7028.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
F. E. Somnier
Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis
Neurology, September 27, 2005; 65(6): 928 - 930.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
F. Romi, G. O. Skeie, N. E. Gilhus, and J. A. Aarli
Striational Antibodies in Myasthenia Gravis: Reactivity and Possible Clinical Significance
Arch Neurol, March 1, 2005; 62(3): 442 - 446.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Vandiedonck, G. Beaurain, M. Giraud, C. Hue-Beauvais, B. Eymard, C. Tranchant, P. Gajdos, J. Dausset, and H.-J. Garchon
Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia
PNAS, October 26, 2004; 101(43): 15464 - 15469.
[Abstract] [Full Text] [PDF]